Un DM portable contre les tumeurs obtient l’approbation de la FDA

La medtech suisse Novocure a annoncé le 15 octobre dernier que la Food and Drug Administration (FDA) américaine avait approuvé son dispositif médical pour le traitement des patients adultes atteints d’un cancer du poumon non à petites cellules (CPNPC) métastatique. Baptisé Optune Lua, ce dispositif portable utilise des champs électriques pour tuer les cellules cancéreuses. L’étude de phase 3 LUNAR a été décisive dans la décision de la FDA, rappelle Novocure dans son communiqué.

À noter : {"date":"202505","chunks":["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","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"]}